Glycaemic goals in patients with type 2 diabetes: current status, challenges and recent advances

被引:22
作者
Khunti, K. [1 ]
Davies, M. [2 ]
机构
[1] Univ Leicester, Dept Hlth Sci, Leicester LE1 6TP, Leics, England
[2] Univ Leicester, Dept Cardiovasc Sci, Leicester LE1 6TP, Leics, England
关键词
antidiabetic drugs; compliance; diabetes mellitus; glycaemic control; HbA1c; weight loss; NEWLY-DIAGNOSED DESMOND; BETA-CELL FUNCTION; 10-YEAR FOLLOW-UP; CARDIOVASCULAR EVENTS; INSULIN-RESISTANCE; SELF-MANAGEMENT; GLUCOSE CONTROL; MYOCARDIAL-INFARCTION; EXENATIDE EXENDIN-4; TREATED PATIENTS;
D O I
10.1111/j.1463-1326.2009.01186.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recommendations for the management of type 2 diabetes include rigorous control of blood glucose levels and other risk factors, such as hypertension and dyslipidaemia. In clinical practice, many patients do not reach goals for glycaemic control. Causes of failure to control blood glucose include progression of underlying pancreatic beta-cell dysfunction, incomplete adherence to treatment (often because of adverse effects of weight gain and hypoglycaemia) and reluctance of clinicians to intensify therapy. There is increasing focus on strategies that offer potential to improve glycaemic control. Structured patient education has been shown to improve glycaemic control and other cardiovascular risk factors in people with type 2 diabetes. Payment of general practitioners by results has been shown to improve glycaemic control. New classes of glucose-lowering agents have expanded the treatment options available to clinicians and patients and include the dipeptidyl peptidase 4 (DPP-4) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists. These new classes of therapy and other strategies outlined above could help clinicians to individualize treatment and help a greater proportion of patients to achieve long-term control of blood glucose.
引用
收藏
页码:474 / 484
页数:11
相关论文
共 106 条
  • [21] Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study
    Donnan, PT
    MacDonald, TM
    Morris, AD
    [J]. DIABETIC MEDICINE, 2002, 19 (04) : 279 - 284
  • [22] Long-term adherence to statin treatment in diabetes
    Donnelly, L. A.
    Doney, A. S. F.
    Morris, A. D.
    Palmer, C. N. A.
    Donnan, P. T.
    [J]. DIABETIC MEDICINE, 2008, 25 (07) : 850 - 855
  • [23] Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes
    Donnelly, L. A.
    Morris, A. D.
    Evans, J. M. M.
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2007, 100 (06) : 345 - 350
  • [24] Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
    Dormandy, JA
    Charbonnel, B
    Eckland, DJA
    Erdmann, E
    Massi-Benedetti, M
    Kmoules, IK
    Skene, AM
    Tan, MH
    Lefébvre, PJ
    Murray, GD
    Standl, E
    Wilcox, RG
    Wlhelmsen, L
    Betteridge, J
    Birkeland, K
    Golay, A
    Heine, RJ
    Korányi, L
    Laakso, M
    Mokán, M
    Norkus, A
    Pirags, V
    Podar, T
    Scheen, A
    Scherbaum, W
    Schernthaner, G
    Schmitz, O
    Skrha, J
    Smith, U
    Taton, J
    [J]. LANCET, 2005, 366 (9493) : 1279 - 1289
  • [25] Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes An Overview of Data from PROactive
    Dormandy, John
    Bhattacharya, Mondira
    de Bruyn, Anne-Ruth van Troostenburg
    [J]. DRUG SAFETY, 2009, 32 (03) : 187 - 202
  • [26] The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
    Drucker, Daniel J.
    Nauck, Michael A.
    [J]. LANCET, 2006, 368 (9548) : 1696 - 1705
  • [27] Enhancing incretin action for the treatment of type 2 diabetes
    Drucker, DJ
    [J]. DIABETES CARE, 2003, 26 (10) : 2929 - 2940
  • [28] Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
    Duckworth, William
    Abraira, Carlos
    Moritz, Thomas
    Reda, Domenic
    Emanuele, Nicholas
    Reaven, Peter D.
    Zieve, Franklin J.
    Marks, Jennifer
    Davis, Stephen N.
    Hayward, Rodney
    Warren, Stuart R.
    Goldman, Steven
    McCarren, Madeline
    Vitek, Mary Ellen
    Henderson, William G.
    Huang, Grant D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (02) : 129 - U62
  • [29] Effect of Depression on Self-Management Behaviors and Health Outcomes in Adults with Type 2 Diabetes
    Egede, Leonard E.
    [J]. CURRENT DIABETES REVIEWS, 2005, 1 (03) : 235 - 243
  • [30] Adherence to oral hypoglycaemic agents prior to insulin therapy in Type 2 diabetes
    Evans, JMM
    Donnan, PT
    Morris, AD
    [J]. DIABETIC MEDICINE, 2002, 19 (08) : 685 - 688